This inventor holds 1 USPTO granted patent. Top assignee: Daicel Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hiroki Negishi: Innovator in Th1-Increasing Agents
Introduction
Hiroki Negishi is a notable inventor based in Wako, Japan. He has made significant contributions to the field of food and pharmaceuticals, particularly in the development of agents that enhance Type 1 helper T cells.
Latest Patents
Hiroki Negishi holds a patent for a Th1-increasing agent that aims to reduce constraints on storage conditions and feeding forms while effectively increasing Th1 levels at lower doses. This innovative agent contains a cellulose derivative as its active ingredient, which has a degree of butyryl substitution ranging from 0.3 to 2.6, and a total degree of substitution between 0.5 and 2.8. His patent represents a significant advancement in immunology and therapeutic applications.
Career Highlights
Hiroki Negishi is associated with Daicel Corporation, where he continues to work on innovative solutions in the pharmaceutical sector. His research focuses on enhancing immune responses through novel compounds, contributing to the advancement of medical science.
Collaborations
Hiroki has collaborated with esteemed colleagues such as Hiroshi Ohno and Tadashi Takeuchi. Their combined expertise fosters a productive environment for innovation and research.
Conclusion
Hiroki Negishi's work in developing Th1-increasing agents showcases his commitment to advancing healthcare solutions. His contributions are vital in the ongoing quest for effective immunological therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile